Literature DB >> 9926078

Age at onset and outcome in schizophrenia are related to the degree of familial loading.

J M Suvisaari1, J Haukka, A Tanskanen, J K Lönnqvist.   

Abstract

BACKGROUND: Recent research suggests that high familial loading is associated with early onset of schizophrenia. Results concerning outcome have been controversial.
METHOD: We assessed the relationship between familial loading, age at onset and outcome in all Finnish patients with schizophrenia born between 1950 and 1969. Patients and their first-degree relatives were identified using nationwide registers. Familial loading scores were calculated for schizophrenia and for combined psychotic disorders, and patients were accordingly classified into three groups: high (n = 761), intermediate (n = 14,247), and low familial loading (n = 725). Linear mixed models and the Cox proportional hazard model were used in the analyses.
RESULTS: Onset was earliest, hospitalisation longest and risk of retirement in receipt of a disability pension highest in the group with high familial loading, with opposite extremes found in the group with low familial loading.
CONCLUSIONS: High familial loading for schizophrenia is associated with early onset and poor outcome of schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9926078     DOI: 10.1192/bjp.173.6.494

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

1.  Advanced paternal age and parental history of schizophrenia.

Authors:  Brian Miller; Jaana Suvisaari; Jouko Miettunen; Marjo-Riitta Järvelin; Jari Haukka; Antti Tanskanen; Jouko Lönnqvist; Matti Isohanni; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2011-09-19       Impact factor: 4.939

2.  Heritability of schizophrenia and major affective disorder as a function of age, in the presence of strong cohort effects.

Authors:  Janice A Husted; Celia M T Greenwood; Anne S Bassett
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-12-05       Impact factor: 5.270

3.  Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients.

Authors:  Michelle Esterberg; Michael Compton
Journal:  Psychiatry Res       Date:  2012-04-14       Impact factor: 3.222

4.  Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2010-08-18       Impact factor: 3.630

5.  Prescription stimulant use is associated with earlier onset of psychosis.

Authors:  Lauren V Moran; Grace A Masters; Samira Pingali; Bruce M Cohen; Elizabeth Liebson; R P Rajarethinam; Dost Ongur
Journal:  J Psychiatr Res       Date:  2015-09-21       Impact factor: 4.791

6.  The identification of family subtype based on the assessment of subclinical levels of psychosis in relatives.

Authors:  Eske M Derks; Marco P M Boks; Jeroen K Vermunt
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630

7.  Incorporation of molecular data and redefinition of phenotype: new approaches to genetic epidemiology of bipolar manic depressive illness and schizophrenia.

Authors:  E S Gershon; J A Badner
Journal:  Dialogues Clin Neurosci       Date:  2001-03       Impact factor: 5.986

8.  Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia.

Authors:  Bao-Yu Chen; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Sheng-Hsiang Lin
Journal:  NPJ Schizophr       Date:  2021-07-05

9.  Diagnostic stability among chronic patients with functional psychoses: an epidemiological and clinical study.

Authors:  Klaus D Jakobsen; Thomas Hansen; Thomas Werge
Journal:  BMC Psychiatry       Date:  2007-08-16       Impact factor: 3.630

10.  Neighborhood-level predictors of age at onset and duration of untreated psychosis in first-episode psychotic disorders.

Authors:  Benson S Ku; Luca Pauselli; Marc Manseau; Michael T Compton
Journal:  Schizophr Res       Date:  2020-01-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.